Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Consolidated Net Income (2016 - 2020)

Historic Consolidated Net Income for Phio Pharmaceuticals (PHIO) over the last 9 years, with Q4 2020 value amounting to -$2.5 million.

  • Phio Pharmaceuticals' Consolidated Net Income rose 775.57% to -$2.5 million in Q4 2020 from the same period last year, while for Sep 2021 it was -$2.5 million, marking a year-over-year increase of 7264.44%. This contributed to the annual value of -$11.5 million for FY2022, which is 1359.98% up from last year.
  • According to the latest figures from Q4 2020, Phio Pharmaceuticals' Consolidated Net Income is -$2.5 million, which was up 775.57% from -$2.3 million recorded in Q3 2020.
  • In the past 5 years, Phio Pharmaceuticals' Consolidated Net Income ranged from a high of -$1.5 million in Q3 2018 and a low of -$5.5 million during Q1 2017
  • Moreover, its 5-year median value for Consolidated Net Income was -$2.2 million (2016), whereas its average is -$2.3 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 14473.33% in 2017, then surged by 5899.27% in 2018.
  • Quarter analysis of 5 years shows Phio Pharmaceuticals' Consolidated Net Income stood at -$2.3 million in 2016, then rose by 14.41% to -$2.0 million in 2017, then grew by 13.74% to -$1.7 million in 2018, then crashed by 54.55% to -$2.7 million in 2019, then increased by 7.76% to -$2.5 million in 2020.
  • Its Consolidated Net Income stands at -$2.5 million for Q4 2020, versus -$2.3 million for Q3 2020 and -$1.7 million for Q2 2020.